T1	Participants 22 80	finasteride-treated subjects and male pseudohermaphrodites
T2	Participants 137 213	Male pseudohermaphrodites (MPHs) with inherited 5 alpha-reductase deficiency
T3	Participants 685 748	was compared with that of men with benign prostatic hyperplasia
